| ZFIN ID: ZDB-EXP-170426-7 |
Experiment Conditions Description: chemical treatment by injection: silicon dioxide nanoparticle, chemical treatment by injection: captopril, visible light
| chemical treatment by injection: silicon dioxide nanoparticle |
|---|
| Name: | chemical treatment by injection |
|---|---|
| Synonyms: | |
| Definition: | Chemical treatment in which the chemical is injected into the zebrafish. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000237] |
| Name: | silicon dioxide nanoparticle |
|---|---|
| Synonyms: | silica nanoparticle |
| Definition: | A nanoparticle consisting of silicon dioxide. |
| Ontology: | ChEBI [CHEBI:50828] ( EBI ) |
| chemical treatment by injection: captopril |
|---|
| Name: | chemical treatment by injection |
|---|---|
| Synonyms: | |
| Definition: | Chemical treatment in which the chemical is injected into the zebrafish. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000237] |
| Name: | captopril |
|---|---|
| Synonyms: | (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid, 1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline, Acepress, Apopril, Capoten, Captolane, captopril, captoprilum, Captopryl, Captoril, Cesplon, CP, D-2-methyl-3-mercaptopropanoyl-L-proline, D-3-mercapto-2-methylpropanoyl-L-proline, Dilabar, Garranil, Hypertil, L-Captopril, Lopirin, Tenosbon, Tensobon, Tensoprel |
| Definition: | A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug. |
| Ontology: | ChEBI [CHEBI:3380] ( EBI ) |
| visible light |
|---|
| Name: | visible light |
|---|---|
| Synonyms: | |
| Definition: | Electromagnetic radiation with a wavelength from 400 nm to 700 nm. Visible light referes to the light which is visible to the human eye and is responsible fo the sense of sight. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000213] |
| Publication: | Tan et al., 2017 |
|---|